• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病精神病的治疗。

Treatment of Parkinson's disease psychosis.

作者信息

Black Kevin J

机构信息

Departments of Psychiatry, Neurology, Radiology and Neuroscience, Washington University in St. Louis.

出版信息

Med Int Rev. 2017 Dec;27(109):266-271. Epub 2018 Feb 3.

PMID:30140115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6103448/
Abstract

Early in the course of Parkinson disease (PD), treatment usually goes well. However, after five to ten years, things start to change as treatment requires higher doses of medications and side effects become more problematic. One of the most difficult problems is the development of hallucinations or delusions. Throughout the 20th century, treatment options were unproven and unsatisfactory, but the past 20 years have brought important changes. Two medications that are well tolerated in PD have now proved efficacious in randomized, controlled trials, and others are in development. Here I summarize this history briefly and provide a general plan for treating the patient with PD complicated by psychotic symptoms.

摘要

在帕金森病(PD)病程早期,治疗通常进展顺利。然而,五到十年后,情况开始发生变化,因为治疗需要更高剂量的药物,且副作用变得更成问题。最棘手的问题之一是出现幻觉或妄想。在整个20世纪,治疗方案未经证实且效果不佳,但在过去20年里出现了重要变化。两种在PD中耐受性良好的药物现已在随机对照试验中证明有效,其他药物也在研发中。在此,我简要总结这段历史,并提供一个治疗伴有精神症状的PD患者的总体方案。

相似文献

1
Treatment of Parkinson's disease psychosis.帕金森病精神病的治疗。
Med Int Rev. 2017 Dec;27(109):266-271. Epub 2018 Feb 3.
2
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.吡贝地尔治疗帕金森病精神病患者的随机、安慰剂对照 3 期试验。
Lancet. 2014 Feb 8;383(9916):533-40. doi: 10.1016/S0140-6736(13)62106-6. Epub 2013 Nov 1.
3
Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis.匹莫范色林:一种用于帕金森病精神病的新型抗精神病药物。
Ann Pharmacother. 2017 Jun;51(6):479-487. doi: 10.1177/1060028017693029. Epub 2017 Feb 1.
4
The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease.酒石酸匹莫范色林治疗帕金森病精神病的安全性、耐受性及疗效
Expert Rev Neurother. 2016 Jun;16(6):625-33. doi: 10.1586/14737175.2016.1158102.
5
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin.美国食品药品监督管理局对新型抗精神病药物匹莫范色林的看法。
J Clin Psychiatry. 2017 Jun;78(6):e668-e673. doi: 10.4088/JCP.16r11119.
6
Pimavanserin for the treatment of Parkinson's disease psychosis.匹莫范色林用于治疗帕金森病精神病。
Expert Opin Pharmacother. 2016 Oct;17(15):2115-24. doi: 10.1080/14656566.2016.1234609. Epub 2016 Sep 15.
7
Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis.匹莫范色林,一种用于治疗帕金森病精神病的新型抗精神病药物。
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1161-1168. doi: 10.1080/17512433.2017.1369405. Epub 2017 Oct 17.
8
Pharmacological interventions for psychosis in Parkinson's disease patients.帕金森病患者精神病的药物干预。
Expert Opin Pharmacother. 2018 Apr;19(5):499-505. doi: 10.1080/14656566.2018.1445721. Epub 2018 Mar 1.
9
Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.治疗帕金森病精神病相关的幻觉和妄想。
Curr Psychiatry Rep. 2018 Jan 27;20(1):3. doi: 10.1007/s11920-018-0869-z.
10
Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist.成功治疗氯氮平难治性幻觉和妄想与匹莫范色林,一种血清素 5HT-2A 受体反向激动剂。
Schizophr Res. 2019 Jun;208:217-220. doi: 10.1016/j.schres.2019.02.018. Epub 2019 Mar 2.

引用本文的文献

1
Potentially Inappropriate Medication Use in Patients With Parkinson's Disease: Analysis of Korean National Health Insurance Claims Data.帕金森病患者潜在不适当用药情况:基于韩国国民健康保险理赔数据的分析
J Clin Neurol. 2025 Sep;21(5):405-414. doi: 10.3988/jcn.2025.0122.
2
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.关于帕金森病精神病的最佳诊断和比哌立登作用的演变。
CNS Drugs. 2024 May;38(5):333-347. doi: 10.1007/s40263-024-01084-1. Epub 2024 Apr 8.
3
Atypical antipsychotic use and mortality risk in Parkinson disease.非典型抗精神病药物在帕金森病中的应用与死亡率风险。
Parkinsonism Relat Disord. 2022 Oct;103:17-22. doi: 10.1016/j.parkreldis.2022.08.013. Epub 2022 Aug 19.
4
A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease.一项关于齐拉西酮治疗帕金森病相关精神病的系统评价和病例系列研究。
J Parkinsons Dis. 2019;9(1):63-71. doi: 10.3233/JPD-181448.

本文引用的文献

1
Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.用于治疗与胆碱能神经变性相关的帕金森病症状的药物疗法。
Expert Opin Pharmacother. 2016 Dec;17(18):2405-2415. doi: 10.1080/14656566.2016.1254189. Epub 2016 Nov 7.
2
Neuropsychiatric Symptoms in Parkinson's Disease: Beyond Complications.帕金森病中的神经精神症状:超越并发症
Front Psychiatry. 2016 Jun 23;7:110. doi: 10.3389/fpsyt.2016.00110. eCollection 2016.
3
Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies.多奈哌齐在阿尔茨海默病和路易体痴呆神经精神症状管理中的作用。
CNS Neurosci Ther. 2016 Mar;22(3):159-66. doi: 10.1111/cns.12484. Epub 2016 Jan 18.
4
Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson's Disease Dementia.多奈哌齐对帕金森病痴呆行为和精神症状的影响。
J Mov Disord. 2015 May;8(2):98-102. doi: 10.14802/jmd.15041. Epub 2015 May 31.
5
A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease.奥氮平治疗帕金森病所致精神病的固定剂量随机对照试验。
F1000Res. 2013 Jul 9;2:150. doi: 10.12688/f1000research.2-150.v1. eCollection 2013.
6
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.吡贝地尔治疗帕金森病精神病患者的随机、安慰剂对照 3 期试验。
Lancet. 2014 Feb 8;383(9916):533-40. doi: 10.1016/S0140-6736(13)62106-6. Epub 2013 Nov 1.
7
Clozapine and agranulocytosis: re-assessing the risks.氯氮平与粒细胞缺乏症:重新评估风险
Australas Psychiatry. 2013 Aug;21(4):335-7. doi: 10.1177/1039856213491990. Epub 2013 Jun 26.
8
Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial.齐拉西酮与氯氮平治疗帕金森病精神症状的随机开放临床试验
Clin Neuropharmacol. 2012 Mar-Apr;35(2):61-6. doi: 10.1097/WNF.0b013e31824d5115.
9
Melperone is ineffective in treating Parkinson's disease psychosis.美哌隆治疗帕金森病精神病无效。
Mov Disord. 2012 May;27(6):803-4. doi: 10.1002/mds.24942. Epub 2012 Feb 23.
10
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.运动障碍学会循证医学综述更新:帕金森病非运动症状的治疗方法。
Mov Disord. 2011 Oct;26 Suppl 3(0 3):S42-80. doi: 10.1002/mds.23884.